It is a pharma private limited company based in Visakhapatnam, Andhra Pradesh, India, established in 2016.
2016 | Visakhapatnam, Andhra Pradesh, India | ActiveRiozen Pharmaceutical Private Limited, a active private limited company, was established on 02 November 2016 in Visakhapatnam, Andhra Pradesh, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U74999AP2016PTC104381. Registered under ROC Roc Vijayawada. it is unlisted. It has an authorized capital of ₹2.50 M and a paid-up capital of ₹2.50 M.
It upholds a compliant status. Its leadership includes Smita Samal (Director), Rajesh Kumar Patra (Director), Kuldeep Bansal (Director). Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 1-1-193,Mvp Colony, Sector-11&12, Indira Nagar, Pedawaltair, Visakhapatnam, Andhra Pradesh, 530017.
U74999AP2016PTC104381
104381
02 November 2016
₹2.50 M
₹2.50 M
Roc Vijayawada
Unlisted
Active
Explore comprehensive insights into Riozen Pharmaceutical Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Smita Samal | Director | 02 Nov 2016 | Current |
| Rajesh Kumar Patra | Director | 02 Nov 2016 | Current |
| Kuldeep Bansal | Director | 02 Nov 2016 | Current |
| Jagdeep Bansal | Director | 02 Nov 2016 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Riozen Pharmaceutical Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 71.7% decrease. The company also saw a substantial fall in profitability, with a 80.89% decrease in profit. The company's net worth moved up by a moderate rise of 0.31%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Riozen Pharmaceutical's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Riozen Pharmaceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Riozen Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Riozen Pharmaceutical's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Riozen Pharmaceutical Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Riozen Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Vijayawada. was recorded as a recent event.
Smita Samal was appointed as a Director was appointed as a Director on 02 Nov 2016 & has been associated with this company since 9 years 30 days . was recorded as a recent event.
The activity Rajesh Kumar Patra was appointed as a Director was appointed as a Director on 02 Nov 2016 & has been associated with this company since 9 years 30 days . was completed.
Kuldeep Bansal was appointed as a Director was appointed as a Director on 02 Nov 2016 & has been associated with this company since 9 years 30 days . was recorded as a recent event.
The activity Jagdeep Bansal was appointed as a Director was appointed as a Director on 02 Nov 2016 & has been associated with this company since 9 years 30 days . was completed.
The CIN of Riozen Pharmaceutical Private Limited is U74999AP2016PTC104381.
Riozen Pharmaceutical Private Limited is headquartered at 1-1-193,Mvp Colony, Sector-11&12, Indira Nagar, Pedawaltair, Visakhapatnam, Andhra Pradesh, 530017.
Riozen Pharmaceutical Private Limited was incorporated on 02 November 2016.
The current directors of Riozen Pharmaceutical Private Limited are
The primary industry of Riozen Pharmaceutical Private Limited is Trade.
Riozen Pharmaceutical Private Limited is unlisted.
The authorized capital of Riozen Pharmaceutical Private Limited is ₹2.50 M, and the paid-up capital is ₹2.50 M.
The compliance status of Riozen Pharmaceutical Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX